SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8555Pru out saying this news does not matter, just SEPR distracting folks from now fRobohogs-7/18/2005
8554sorry... a bit more info.......http://biz.yahoo.com/bw/050718/185122.html?.v=1Iamarangerboy-7/18/2005
8553biz.yahoo.com Sepracor Posts Positive Lunesta Trial Monday July 18, 8:33 am ET Iamarangerboy-7/18/2005
8552Folks, let's guess the revenue number. My best guess says $160 MM, well aboRobohogs-7/18/2005
8551The contributors to this thread rock. Great thread, start to now. I'm an oscaram(o)uche-7/15/2005
8550Thanks software salesperson and Peter. DMF filing by Aspen doesn't bother mkenhott-7/15/2005
8549>> BTW folks should occasionally stick a lowball bid on aftermarket sites scaram(o)uche-7/15/2005
8548Actually there are two DMF's on file for levalbuterol - one by Teva's ItBiomaven-7/15/2005
8547from lehman: RECENT DMF FILING ON XOPENEX UNLIKELY TO TRANSLATE TO GENERIC COMPsoftware salesperson-7/15/2005
8546Sorry but was in a rush this morning. What I'd meant to type was that a DMFkenhott-7/15/2005
8545They did not really say other than there are quite a few different patents to geRobohogs-7/15/2005
8544A DMF is not required for an ANDA (or for a new drug). Looks like TEVA is signakenhott-7/15/2005
8543What kind of idiot sells 1300 hundred sales right as Instinet opens down $5? NoRobohogs-7/15/2005
8542Somebody just sold 1300 shares at $54.01 pre-mkt. Bid ask structure is $54.12 -Robohogs-7/15/2005
8541Sanofi gets wake-up call from sleeping pill rivals Thu Jul 14, 2005 10:25 AM ET Icebrg-7/14/2005
8540Stock moving on Lehman reiterating support and raising peak L sales to $900 MM fRobohogs-7/14/2005
8539I didn't see the panel meeting, but obviously serevent not being pulled fromrkrw-7/14/2005
8538Hey rkrw, Do you have any insights to share about THRX's LABAs in relationskenhott-7/14/2005
8537Well Xopenex limped into quarter end while Lunesta strengthened. Looking at theRobohogs-7/13/2005
8536US panel - Novartis asthma drug should stay on market Wed Jul 13, 2005 04:25 PM kenhott-7/13/2005
8535The chance of Advair/Serevent being taken off the market is small. The chance tkenhott-7/13/2005
8534nytimes.com What are implications for r,r-formoterol?Harold Engstrom-7/13/2005
8533SEPR price continues to fall. On the yahoo board, there was a scrips posting as Iamarangerboy-7/12/2005
8532That's a whole lot of scrips: <i> VNU Agrees to Buy Data Colletom pope-7/11/2005
8531I don't think this explanation works as JPM analysts have not published anytRobohogs-7/9/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News